Schedule 13G ownership disclosure

IMMUNOGEN INC

Security class unavailable · CUSIP: 45253H101

Event date: 2022-03-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,586,193
Percent of class
5.2500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-22-002401
Form type
SC 13G
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Apr 04, 2022
Reporting period
Mar 23, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub